Waste Management To Acquire Stericycle For $62.00/Share In Cash, At 20% Premium
Waste Management agreed to acquire Stericycle, adding medical waste & document shredding services. Both stocks have seen gains in past 12 months.
Honeywell Takes Flight: Boosts Guidance, Closes Carrier Global Transaction
Honeywell raised guidance after completing acquisition of Carrier's Global Access Solutions business, expecting growth in automation and aviation. Q2 & FY24 outlooks improved with strong cash flow and margin expansion.
Salesforce And Celsius Were Among The 10 Biggest Large Cap Losers Last Week: Are These In Your Portfolio?
10 large-cap stocks worst performers last week: MongoDB, Nutanix, DraftKings, Salesforce, Samsara, Celsius, Agilent, Snowflake, ServiceNow, Hormel. Are they in your portfolio?
NIO And Best Buy Were Among 10 Stocks That Shined The Brightest Last Week: Are They In Your Portfolio?
Top stocks last week: BIRK, BURL, DKS, BBY, CAVA, NIO, HPQ, MRO, RL, ONON. Strong earnings, raised guidance, and analysts' price target boosts.
FDA Expands Approval For Bristol Myers Squibb’s Breyanzi, Making CAR T Cell Therapy Available For Broadest Range Of B-Cell Malignancies
FDA approves Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel) for relapsed or refractory mantle cell lymphoma, marking its fourth non-Hodgkin lymphoma subtype indication.
Novartis Sues to Block Maryland’s New Drug Discount Law
Novartis has filed a lawsuit to block a Maryland law requiring drugmakers to offer discounts on drugs through third-party pharmacies contracting with hospitals and clinics.
Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes
Novo Nordisk has filed lawsuits against nine additional U.S. medical spas, wellness clinics, and pharmacies for selling impure or falsely labeled semaglutide products.
Pfizer Highlights ‘Unprecedented’ 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer
Pfizer's Phase 3 CROWN trial results show Lorbrena significantly outperforms Xalkori in treating ALK-positive advanced NSCLC.
Tech Stocks Crumble As Wall Street’s 5-Week Rally Ends; Bonds Offer Safe Haven As Growth Worries Reemerge: What’s Driving Markets Friday?
Bears knocked on Wall Street’s door again Friday, sending large-cap tech stocks lower despite the Fed’s favorite inflation measure meeting expectations.
Moderna’s Scores FDA Approval For Its Second Product – Respiratory Syncytial Virus Vaccine
FDA approves Moderna's mRESVIA (mRNA-1345), an mRNA vaccine for RSV, for adults 60+. The second approved mRNA product from Moderna.